Clinical Study
Prophylactic Administration of Surfactant in Extremely Premature Infants
Table 1
Patients’ characteristics.
| | Prophylactic surfactant group (observational period) | Selective surfactant group (historical control) | Significance |
| | Birthwight (g) | | | n.s. | | Gestational age (wksd) | | | n.s. | | Male sex (%) | 54 | 41 | n.s. | | Antenatal steroids (%) | 90 | 91 | n.s. | | APGAR-Score (5 minutes) | 7 | 7 | n.s. | | SGA (%) | 29 | 15 | n.s. | | Multiple births (%) | 7 | 9 | n.s. | | GA 24 wks (%) | 19 | 18 | n.s. |
|
|
SGA:small for gestational age (birth weights below 10th percentile); GA:gestational age; wks, weeks; d, days.
|
